FDA posts observations from AstraZeneca site inspection
The FDA posted to its site the observations made during an inspection of an AstraZeneca (AZN) manufacturing center that was conducted from May ...
AstraZeneca boosts China presence with FibroGen's anemia drug in $160 million deal
(Reuters) -AstraZeneca will buy longtime partner FibroGen's China unit for about $160 million to gain rights to its anemia drug in the country, further boosting its presence in the world's ...
BioPharma Dive11h
AstraZeneca deepens China presence with FibroGen deal
The $160 million acquisition of a FibroGen subsidiary expands AstraZeneca’s foothold in China while the company works through ...
M&A News: AstraZeneca Expands China Footprint With FibroGen Deal
AstraZeneca (AZN) is set to acquire U.S. biotech company FibroGen’s (FGEN) China unit for $160 million to expand its presence in the country.